[Oral administration of OK-432 (Picibanil) (7th report). Clinical application: effects on advanced and recurrent cancers].
Nio
Y
Y
Ohgaki
K
K
Kan
N
N
Tsuchitani
T
T
Imai
S
S
Okino
T
T
Hori
T
T
Tobe
T
T
Nakamura
M
M
Kodama
H
H
D000284:Administration, Oral; D000368:Aged; D000369:Aged, 80 and over; D001688:Biological Products / Q000008:administration & dosage*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy*; D010844:Picibanil / Q000008:administration & dosage* / Q000627:therapeutic use; D010865:Pilot Projects
D001688:Biological Products; D010844:Picibanil